Pfizer, BioNTech — Both U.S. drugmaker Pfizer and German biotechnology company BioNTech rose on Monday after they reported additional data from their experimental Covid-19 vaccine. The new data showed their candidate both was safe and induced an immune response in patients. It also showed the vaccine candidate triggered an induction of a high level of T-cell responses. Pfizer gained 0.35% in the U.S. while BioNTech added 5.2% on Monday.
Bull-markets are born on pessimism, grow on skepticism, mature on optimism and die on euphoria .. Sir John Templeton
Make your Life a Mission .... NOT an Intermission. † §|PL1|§